Knut Jørgen Labori - Concepedia

Author

Knut Jørgen Labori

Also Known As

Dyre Kleive, Giuseppe K. Fusai, K J Labori, K. J. Labori, K. J. Labori, B. A. Bjørnbeth, E. H, K. Labori, K.J. Labori, Knut J Labori, Knut J. Labori, Knut Joergen Labori

219

Publications

10.4K

Citations

H-Index

Concepts

All Affiliations

Oslo University Hospital University of Oslo Akershus University Hospital Karolinska Institutet Institutt for Eksperimentell Medisinsk Forskning

About

Knut Jørgen Labori is an author at Oslo University Hospital specializing in medicine, surgery, and surgical oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	25	8.4K
2	Health Sciences	4	4	143
3	Engineering	1	1	15
4	Biochemistry	1	1	10
5	Biomedical Engineering	1	1	32

Knut Jørgen Labori

Publications

9.8K

Citations

H-Index

Page 1

	Year	Citations
Tumour exosome integrins determine organotropic metastasis Ayuko Hoshino, Bruno Costa‐Silva, Tang‐Long Shen, Nature MedicinePathologyCell-matrix InteractionExtracellular MicrovesiclesExosome Integrins	2015	4.9K
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver Bruno Costa‐Silva, Nicole M. Aiello, Allyson J. Ocean, Nature Cell Biology Tumor BiologyPancreatic CancerHepatologyExosomesMedicine	2015	2.6K
Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial Knut Jørgen Labori, Svein Olav Bratlie, Bodil Andersson, The Lancet. Gastroenterology & hepatology Surgical OncologyPancreatic CancerGastrointestinal OncologyMedicinePancreatic Surgery	2024	174
Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma – A population-based cohort study Knut Jørgen Labori, Matthew H. G. Katz, C.W. Tzeng, Acta Oncologica	2015	152
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment Stijn van Roessel, Eran van Veldhuisen, Sjors Klompmaker, JAMA Oncology	2020	131
Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) – study protocol for a national multicentre randomized controlled trial Knut Jørgen Labori, Kristoffer Lassen, Dag Hoem, BMC Surgery	2017	99
Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative Study Sven‐Petter Haugvik, Eva Tiensuu Janson, Pia Österlund, Annals of Surgical Oncology Neuro-oncologyEndocrine OncologySurgical OncologyPancreatic CancerSurgical Treatment	2015	86
Symptom profiles and palliative care in advanced pancreatic cancer—a prospective study Knut Jørgen Labori, Marianne Jensen Hjermstad, Torunn Wester, Supportive Care in Cancer Palliative CarePancreatic CancerMedicineGastroenterologyPathology	2006	84
Pancreatic MRI for the surveillance of cystic neoplasms: comparison of a short with a comprehensive imaging protocol Raffaella Pozzi Mucelli, Irina Rinta‐Kiikka, K. Wünsche, European Radiology Pancreatic CancerMedical ImagingPancreatic Fluid CollectionSurgical PathologyPancreatic Mri	2016	73
Regulatory T cells that co-express RORγt and FOXP3 are pro-inflammatory and immunosuppressive and expand in human pancreatic cancer Stalin Chellappa, Harald Hugenschmidt, Morten Hagness, OncoImmunology	2015	68

Page 1